Device
Fitbit Charge HR®
Fitbit Charge HR® is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
1
20%
Ph not_applicable
3
60%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
A Mobile Health Intervention in Pulmonary Arterial Hypertension
NCT03069716
completedphase_1
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
NCT02932215
completednot_applicable
Accuracy of Commercially Available Heart Rate Monitors
NCT02697214
completed
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer
NCT02659358
unknownnot_applicable
Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR Device
NCT02788929
Clinical Trials (5)
Showing 5 of 5 trials
NCT03069716Not Applicable
A Mobile Health Intervention in Pulmonary Arterial Hypertension
NCT02932215Phase 1
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
NCT02697214Not Applicable
Accuracy of Commercially Available Heart Rate Monitors
NCT02659358
Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer
NCT02788929Not Applicable
Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR Device
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5